Skip to main content

Table 3 Summary of the clinical characteristics of the patients referred to the hospital with suspected Acute Hemolytic Anaemia

From: Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth

  Age/Sex Treatment regimen Indication Relevant comorbidities; comedication G6PD deficiency Haemolysis Hemoglobin (g/dL) Serum bilirubin, total/conjugated, mg/dL Transaminases (U/L) Hospitalization period until discharge
(days)
Case 1 11/M Short standard regimen QC + PQ Mixed malaria (p.falciparum & vivax) None; Dipyrone Yes No 12.06 1.57/ 0.50 AST: 56
ALT: 30
4 days
Case 2 35/M Short standard regimen QC + PQ Malaria p.Vivax None; Dipyrone Yes Yes 12.83 4.65/1.72 AST: 231
ALT: 305
0 days
Case 3 24/F Short standard regimen QC + PQ Malaria p.Vivax None; No Yes No 12.38 0.52/0.20 AST: 32
ALT:52
1 day
  1. G6PD: glucose-6-phosphate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase